Showing results (261-270 of 673) with videos related to

Sort By:
Pageof 68
Intestinal Research|November 5, 2020
High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitisSaransh Jain, Divya Namdeo, Pabitra Sahu, et al.
Intestinal Research|November 19, 2020
Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn's disease: 3-year results from a real-world studyTadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, et al.
Intestinal Research|June 1, 2022
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapiesPriscila A Lima, Bárbara B Berg, Marina Gomes Miranda E Castor
Intestinal Research|June 10, 2022
Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn's disease in tuberculosis endemic areasKaran Sachdeva, Peeyush Kumar, Bhaskar Kante, et al.
Intestinal Research|November 2, 2020
Clinical management for small bowel of Crohn's disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesionKenji Watanabe
Intestinal Research|February 5, 2020
Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseasesSang Hyoung Park, Jae Cheol Park, Milan Lukas, et al.
Intestinal Research|February 6, 2020
Hypermethylated promoters of tumor suppressor genes were identified in Crohn's disease patientsTae-Oh Kim, Yu Kyeong Han, Joo Mi Yi
Intestinal Research|July 22, 2021
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort studySeung Yong Shin, Soo Jung Park, Young Kim, et al.
Intestinal Research|February 2, 2021
Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?Nor Hamizah Shafiee, Zahara Abdul Manaf, Norfilza M Mokhtar, et al.
Intestinal Research|February 2, 2021
Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort studyVitaliy Y Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, et al.
Pageof 68